Keudell Astrazeneca PLC Transaction History

Keudell

$372 Million
Q4 2024

A detailed history of Keudell transactions in Astrazeneca PLC stock. As of the latest transaction made, Keudell holds 4,707 shares of AZN stock, worth $366,957. This represents 0.08% of its overall portfolio holdings.

Number of Shares

4,707

Previous 4,596 2.42%

Holding current value

$366,957

Previous $358,000 13.97%

% of portfolio

0.08%

Previous 0.1%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 23, 2025	BUY	$63.2 - $79.58 $7,015 - $8,833	111 Added 2.42%	4,707 $308,000
Q3 2024 Oct 31, 2024	SELL	$76.67 - $87.62 $5,980 - $6,834	-78 Reduced 1.67%	4,596 $358,000
Q2 2024 Jul 16, 2024	BUY	$66.81 - $80.83 $200 - $242	3 Added 0.06%	4,674 $364,000
Q1 2024 May 07, 2024	BUY	$61.03 - $69.57 $183 - $208	3 Added 0.06%	4,671 $316,000
Q4 2023 Feb 14, 2024	BUY	$61.89 - $69.28 $23,146 - $25,910	374 Added 8.71%	4,668 $314,000
Q3 2023 Oct 18, 2023	BUY	$64.85 - $71.7 $843 - $932	13 Added 0.3%	4,294 $290,000
Q1 2023 Apr 18, 2023	BUY	$63.15 - $71.6 $5,746 - $6,515	91 Added 2.17%	4,281 $297,000
Q4 2022 Jan 20, 2023	SELL	$54.21 - $70.44 $7,480 - $9,720	-138 Reduced 3.19%	4,190 $0
Q3 2022 Oct 12, 2022	BUY	$53.02 - $135.75 $3,499 - $8,959	66 Added 1.55%	4,328 $237,000
Q2 2022 Jul 18, 2022	SELL	$59.26 - $71.14 $12,740 - $15,295	-215 Reduced 4.8%	4,262 $282,000
Q1 2022 Apr 18, 2022	SELL	$55.72 - $67.12 $47,194 - $56,850	-847 Reduced 15.91%	4,477 $297,000
Q4 2021 Feb 08, 2022	BUY	$54.02 - $63.83 $20,311 - $24,000	376 Added 7.6%	5,324 $310,000
Q3 2021 Oct 20, 2021	SELL	$55.56 - $60.79 $166 - $182	-3 Reduced 0.06%	4,948 $297,000
Q2 2021 Jul 13, 2021	SELL	$48.42 - $60.18 $11,572 - $14,383	-239 Reduced 4.61%	4,951 $297,000
Q1 2021 Apr 13, 2021	SELL	$47.16 - $54.44 $20,750 - $23,953	-440 Reduced 7.82%	5,190 $258,000
Q4 2020 Feb 12, 2021	SELL	$48.52 - $58.02 $21,494 - $25,702	-443 Reduced 7.29%	5,630 $281,000
Q3 2020 Oct 20, 2020	BUY	$53.07 - $61.1 $6,580 - $7,576	124 Added 2.08%	6,073 $333,000
Q2 2020 Jul 14, 2020	BUY	$43.1 - $55.31 $4,913 - $6,305	114 Added 1.95%	5,949 $315,000
Q1 2020 Apr 20, 2020	BUY	$37.79 - $51.33 $34,124 - $46,350	903 Added 18.31%	5,835 $261,000
Q4 2019 Jan 29, 2020	SELL	$42.46 - $50.46 $5,519 - $6,559	-130 Reduced 2.57%	4,932 $246,000
Q3 2019 Nov 13, 2019	SELL	$40.12 - $45.47 $34,503 - $39,104	-860 Reduced 14.52%	5,062 $226,000
Q2 2019 Aug 23, 2019	BUY	$37.28 - $41.68 $220,772 - $246,828	5,922 New	5,922 $260,000
Q2 2019 Aug 21, 2019	SELL	$37.28 - $41.68 $217,864 - $243,577	-5,844 Closed	0 $0
Q1 2019 Aug 21, 2019	BUY	$35.49 - $43.02 $207,403 - $251,408	5,844 New	5,844 $236,000

Others Institutions Holding AZN

# of Institutions

1,365

Shares Held

512M

Call Options Held

6.08M

Put Options Held

4.44M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $242B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Keudell, based on Form 13F filings with the SEC.

News

Stay updated on Keudell with notifications on news.

Account